Our aim in this study is to systematically review and meta-analyze all studies that examined the frequency of KRAS and BRAF mutations in different regions of Iran to obtain a more accurate estimate of KRAS and BRAF mutation rate in Iranian CRC patients. Here, KRAS is linked to colorectal carcinoma.